ABSTRACT
Background: Nucleolin is a multifunctional nucleolar protein with RNA-binding properties. Increased nucleolin expression protects cells from H2O2-induced damage, but the mechanism remains unknown. Long noncoding RNAs (lncRNAs) play crucial roles in cardiovascular diseases. However, the biological functions and underlying mechanisms of lncRNAs in myocardial injury remain unclear.
Methods: In a nucleolin-overexpressing cardiac cell line, high-throughput technology was used to identify lncRNAs controlled by nucleolin. Cell counting kit-8 assay was used to determine cell viability, lactate dehydrogenase (LDH) assay to detect cell death, caspase activity assay and propidium iodide staining to confirm cell apoptosis, and RNA immunoprecipitation to examine the interaction between Fendrr and nucleolin.
Results: We found that Fendrr expression was significantly downregulated in mouse hearts subjected to myocardial ischemia-reperfusion (MI/R) injury. High Fendrr expression abrogated H2O2-mediated injury in cardiomyocytes as evidenced by increased cell viability and decreased cell apoptosis. Conversely, Fendrr knockdown exacerbated the cardiomyocytes injury. Also, nucleolin overexpression inhibits Fendrr downregulation in H2O2-induced cardiomyocyte injury. Fendrr overexpression significantly reversed the role of the suppression of nucleolin expression in H2O2-induced cardiomyocytes.
Conclusion: LncRNA Fendrr is involved in the cardioprotective effect of nucleolin against H2O2-induced injury and may be a potential therapeutic target for oxidative stress-induced myocardial injury.
Introduction
Nucleolin (also known as C23) is a multifunctional protein commonly expressed in eukaryotic cells [Citation1]. Nucleolin is essential for ribosome biogenesis and RNA metabolism [Citation2]. It participates in a variety of biological processes, including gene replication, transcription, gene silencing, cell cycle regulation, and cell death [Citation3]. Our previous research has shown that oxidative stress causes nucleolin cleavage and apoptosis in C2C12 myogenic [Citation4] and human umbilical vein endothelial cells [Citation5]. Nucleolin overexpression inhibits hydrogen peroxide (H2O2)-induced apoptosis [Citation6]. It protects the heart by interacting with other molecules, resulting in a smaller infarcted area and reduced cardiomyocyte death [Citation7, Citation8]. Although research has shown that nucleolin plays a significant protective role in cardiomyocyte injury, its precise molecular mechanism remains unknown.
The protein-coding genes account for only approximately 2–3% of the human genome, and the majority of the remaining genes are transcribed into noncoding RNA (ncRNA) [Citation9]. Long ncRNAs (lncRNAs) are transcripts with more than 200 nucleotides and limited coding potential. The nomenclature of lncRNAs depends on multiple characteristics such as the transcription initiation point, cell or tissue specificity, molecular function, and mechanism of action [Citation10]. Recently, lncRNAs have been implicated as important gene regulators in cardiac remodeling, myocardial hypertrophy, and myocardial ischemia-reperfusion (MI/R) injury [Citation11–13]. The rapid development of RNA sequencing technology has revealed that lncRNAs are abnormally expressed in various diseases. The biological functions and mechanisms of lncRNAs in various diseases have also been extensively studied.
Cardiovascular diseases and their consequences are the most common health problems in humans. Extensive research has been conducted on the pathogenesis of cardiovascular disease, such as oxidative stress and activation of cell death systems [Citation14]. In vitro H2O2 stimulation of cardiomyocytes is the most common way to simulate MI/R models [Citation15–17]. Recently, new molecular mechanisms have been proposed for cardioprotection against MI/R injury. However, effective drugs and methods for improving reperfusion-related injuries are still lacking. Therefore, an in-depth understanding of the mechanism underlying reperfusion injury and identification of new targets are crucial for preventing and treating cardiomyocyte injury.
This study aimed to investigate the molecular mechanism underlying the protective effect of nucleolin against cardiomyocyte injury. The expression profile of lncRNAs in cardiomyocytes overexpressing nucleolin was elucidated using high-throughput screening technology. We used a mouse model of MI/R injury to detect the expression of lncRNA Fendrr and observed the protective effect of Fendrr in H2O2-induced cardiomyocyte injury. We found that Fendrr is relevant to the protective role of nucleolin, which regulates Fendrr expression. This suggests lncRNA Fendrr involvement in the cardioprotective effect exerted by nucleolin against H2O2-induced injury.
Material and methods
Animal experiments
All animal experiments were performed in conformance with the Animal Experimentation Guidelines of the Medical Ethics Committee of Xiangya Hospital and Central South University (No. 201402027). The animals were subjected to cardiac ischemia-reperfusion damage as previously described (Jiang et al., 2013, 2014). Briefly, BALB/c mice were separated into experimental (n = 3) and sham operation (n = 3) groups. The mice were sedated with pentobarbital (50 mg/kg) every 2 h. Under sterile conditions, left thoracotomy was performed in the fourth intercostal space to expose the heart. MI/R was induced by occluding the left anterior descending coronary artery (LAD) for 30 min, followed by reperfusion for 0, 2, 6, 12, and 24 h. The animals in the sham group underwent the same procedures as those in the experimental group with the exception of ligation. Following reperfusion, the heart was removed at specific time points for histological and morphological examination.
LncRNA profiling
Using the Aglient Rat lncRNA microarray V2.0 (Arraystar, Rockville, MD, USA), three sample pairs were prepared for lncRNA microarray analysis in the nucleolin-overexpressing rat cardiomyocyte cell line and control group. The slides were incubated for 17 h in an Agilent hybridization chamber at 65°C and scanned using the Agilent scanner G2505B. Agilent Feature Extraction software (version 11.0.1.1) was used to analyze the acquired array images. Quantile normalization and subsequent data processing were conducted using GeneSpring GX v12.1 software package (Agilent Technologies, Santa Clara, CA, USA). Differentially expressed lncRNAs between the two groups were identified through paired t-test (P < 0.05 and fold-change > 2.0). All microarray experiments were performed by Kangcheng Bio-Tec (Shanghai, China).
Immunofluorescence assays and fluorescence in situ hybridization (FISH)
Cy3-labeled Fendrr and a Fluorescent In Situ Hybridization Kit (RiboBio, Guangzhou, China) were used according to the manufacturer's instructions. Briefly, H9c2 cells were fixed with 4% v/v paraformaldehyde for 10-min after the cells attained 70–80% confluency. Hybridization was then performed at 37°C overnight using a Fendrr probe. Subsequently, the cells were stained with DAPI and the images were acquired using an Olympus IX71 inverted microscope.
Cell culture and treatment
H9c2 cells were obtained from the American Type Culture Collection and cultured in Dulbecco's modified Eagle's medium supplemented with 10% v/v fetal bovine serum. The cells were cultured at 37 °C in a humidified incubator under 5% v/v CO2. At 70–80% confluence, cellular oxidative stress was induced by exposure to different H2O2 concentrations for different time periods.
Cell transfection experiments
After the H9c2 cells attained 70–80% confluency, they were transfected with recombinant lentiviruses housing the pHS-AVC-LW1120 (Fendrr) and pHS-BVC-LW280 (negative control) constructs (Syngentech; Beijing, China) for 72 h. Also, the H9c2 cells at 80% confluency were transfected with a nucleolin plasmid (pcDNA3-Nuc) and incubated in a CO2 incubator for 48 h at 37°C. For small interfering RNA (siRNA) transfection, nucleolin or Fendrr siRNA (si-C23 or si-Fendrr) and the corresponding negative control siRNA (si-NC or si-nc; Invitrogen Life Technologies) were transfected into cells. Lipofectamine 2000 reagent (Invitrogen) was used for cell transfection according to the manufacturer's instructions. After 48 h of transfection, the cells were lysed for further experiments.
Propidium iodide staining
Propidium iodide (PI) fluorescence staining was used to detect cell death. In summary, the cells were stained with 1 µg/mL of PI staining reagent (Dingguo Biotechnology Co., Ltd.) for 10 min, washed twice with PBS, and observed. The cells positive for apoptosis displayed red fluorescence. Honchest was used for nuclear staining.
RNA isolation and qRT-PCR analysis
Total RNA was isolated from mouse myocardial tissues and cardiomyocytes using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Total RNA was reverse-transcribed into complementary DNA using a Reverse Transcription Kit (Takara, Dalian, China). To determine Fendrr expression levels, quantitative reverse transcription polymerase chain reaction (RT-qPCR) was performed using an Applied Biosystems 7500 Fast Real-Time PCR System (Foster City, CA, USA). GADPH was used as an internal control in myocardial tissues and cardiomyocytes. Relative gene expression levels were analyzed using the 2−ΔΔCT method. The sequences of primers are shown in below table, primers analyses by NCBI blast search were used to identify the specificity of the amplified product.
Cell viability assay
Cell viability was assessed using a Cell Counting Kit-8 assay (CCK-8; Dojindo, Kumamoto, Japan). The cultured cells were seeded at a density of 2-4 × 103 cells/well in 96-well plates. After cell transfection, the medium was replaced with 100 μL of complete culture medium with or without H2O2. CCK-8 reagent (1:100) was added to the wells, and the wells were incubated for 1 h. The absorbance of the samples was measured at 450 nm using a microtiter reader. All experiments were performed in triplicates.
Lactate dehydrogenase (LDH) assay
Cells were seeded in 6- or 12-well plates. After cell transfection, the medium was replaced with complete culture medium with or without H2O2. The assay was performed using a lactate dehydrogenase (LDH) assay kit (Nanjing Jiancheng Bioengineering Institute). Absorbance was measured using a microplate reader at a wavelength of 450 nm.
Caspase activity assay
Caspase activity was analyzed using an ELISA kit (Abcam) according to the manufacturer’s instructions. Briefly, the cells were lysed using a homogenous reagent provided by the manufacturer. Lysates were then added to each well for analysis. Caspase-3 antibody (CST) was added with the detection reagent and incubated at room temperature for 15 min. The absorbance was measured at 450 nm.
RNA immunoprecipitation (RIP) assay
The Magna RIP Kit (Millipore) was used for the RNA immunoprecipitation (RIP) assay according to the manufacturer's protocol. Cardiomyocytes were dissolved in RIP lysis buffer, followed by overnight incubation with anti-nucleolin antibody-conjugated protein A/G beads at 4 °C. After washing off the unbound materials, the RNAs bound to nucleolin were eluted and quantified. The purified RNA was analyzed using RT–PCR.
Statistical analysis
The data were analyzed using SPSS 19.0 software. All data are presented as mean ± standard error of the mean (SEM). Differences between three or more groups were analyzed using Student's t-test and one-way analysis of variance (ANOVA). The results were considered statistically significant at P < 0.05.
Results
LncRNAs regulated by nucleolin in cardiomyocytes
Nucleolin exerts a protective effect on the myocardium; however, the underlying mechanism is unclear. We used nucleolin-overexpressing cardiomyocyte cell lines to investigate the mechanism underlying the protective effect of nucleolin in the myocardium. In total, 267 differentially expressed lncRNAs (181 upregulated and 96 downregulated) were screened using high-throughput sequencing technology and compared with that in the control group (A). These results suggest that nucleolin may regulate the expression of these lncRNAs. Based on the literature and chip data, we chose 15 differentially expressed lncRNAs (B) for protein-RNA immunoprecipitation experiments. We discovered that eight lncRNAs including NR_027324, NR_126575 (Fendrr), U57362, NR_111959, AF167308, and MRAK159688 could bind to nucleolin (C). Fendrr has multiple binding sites (D), implying that nucleolin may directly bind and regulate Fendrr expression. However, few studies have explored the effects of Fendrr on myocardial injury, and in-depth research on Fendrr functional mechanisms in myocardial injury remains unexplored.
LncRNA Fendrr expression down-regulated in myocardial injury
To investigate the expression of Fendrr in myocardial injury, we established a mouse model of MI/R injury and observed changes in electrocardiograms (A), serum creatine kinase (B) levels, and hematoxylin–eosin staining (C), which suggested that the mouse model of MI/R injury was successful. We then detected Fendrr expression in the injured mouse heart tissues at different time points using qRT-PCR. The results showed that Fendrr expression level decreased to the lowest level after 6 h but gradually increased at 12 h and approached the basal level at 24 h of reperfusion (D). We used RNA FISH to determine the degree of Fendrr localization in cardiomyocytes and confirmed high Fendrr enrichment in the cytoplasm of H9c2 cells (E). H2O2 treatment of H9c2 cells simulated cardiomyocyte injury in vitro. We found that Fendrr expression significantly decreased in the H2O2-induced cardiomyocyte injury model with increasing H2O2 concentrations (F), whereas its expression gradually decreased as the duration of H2O2 treatment increased (G). Thus, Fendrr was downregulated in MI/R injury and cardiomyocyte injury induced by oxidative stress.
LncRNA Fendrr relieved H2O2-induced cardiomyocyte injury
To explore the role of Fendrr in H2O2-induced cardiomyocyte injury, we knocked down its expression using small interfering RNA (siRNA) and overexpressed it in H9c2 cardiomyocytes (A). LDH was released from cardiomyocytes and the upregulation of Fendrr reduced LDH release from injured cardiomyocytes after H2O2 treatment (B). Evaluating the cell viability post H2O2-induced cardiomyocyte injury, we found that Fendrr overexpression alleviated the decrease in cell viability induced by H2O2; however, cell viability further decreased after Fendrr knockdown (C). Caspase-3 activity was detected in cardiomyocytes, and the data showed that Fendrr overexpression alleviated the cell apoptosis induced by H2O2; however, cell apoptosis further increased after reducing Fendrr (D). Propidium iodide staining indicated apoptosis by staining the nuclei of H2O2-treated cardiomyocytes red, indicating cell damage. Fendrr upregulation significantly reversed H2O2-induced damage in cardiomyocytes compared to that in H2O2-treated cells (E). Thus, Fendrr protects cardiomyocytes from H2O2-induced injury.
Nucleolin up-regulated the expression of LncRNA Fendrr in H2O2-induced cardiomyocytes injury
To investigate the effect of nucleolin on Fendrr expression in cardiomyocytes, H9c2 cells overexpressing nucleolin were treated with H2O2 for 12 h, and nucleolin overexpression increased the expression of Fendrr in H2O2-induced cardiomyocyte injury (A). RIP results also revealed that nucleolin could bind to Fendrr (B). Thus, nucleolin regulates Fendrr expression by interacting with Fendrr in cardiomyocytes.
Nucleolin protects H2O2-induced injury by up-regulating Fendrr in cardiomyocytes
To further explore the effect of Fendrr on the cardioprotective role of nucleolin during oxidative stress, we co-transfected the cells with Fendrr lentiviral vector and nucleolin siRNA. The results indicated that low nucleolin expression could further promote the decline of cardiomyocyte viability caused by H2O2, but Fendrr overexpression in cells with nucleolin knockdown showed significantly improved cell viability after H2O2 treatment (A). Similarly, we measured LDH levels in the cell culture medium and found that Fendrr overexpression partially inhibited LDH release from H2O2-treated cells (B). Furthermore, we co-transfected Fendrr siRNA and a nucleolin vector into H9c2 cells, and low Fendrr expression eliminated the protective effect of nucleolin against H2O2-induced cardiomyocyte injury (C). Thus, nucleolin could interact with Fendrr, upregulate Fendrr expression, and inhibit H2O2-induced cell apoptosis in cardiomyocytes (D). Fendrr is involved in the protective effects of nucleolin in cardiomyocytes during oxidative stress.
Discussion
LncRNAs play numerous roles in biological processes. Many studies have investigated the intracellular mechanisms of functional lncRNAs, which can bind to multiple molecules [Citation18, Citation19]. lncRNA Fendrr was discovered for the first time during its interaction with polycomb inhibitory complex 2 (PRC2) during mouse heart development [Citation20]. According to bioinformatics analysis and RIP experiment results, Fendrr may bind to the PRC2 complex and the MLL histone modification complex to play a functional role [Citation21–23]. Fendrr enhances doxorubicin resistance in doxorubicin-resistant and-sensitive human osteosarcoma cells by negatively regulating the post-transcriptional expression of the multidrug resistance-related proteins ABCB1 and ABCC1 [Citation24]. Fendrr transcription levels are negatively correlated with SOX4 protein levels in colon cancer; SOX4 protein is one of the binding targets of Fendrr, and Fendrr-mediated SOX4 inhibition may be essential in reducing colon cancer progression [Citation25]. However, the role of Fendrr in human cardiovascular disease remains unclear. The negative association of Fendrr levels in peripheral blood mononuclear cells with the left ventricular mass index in hypertensive individuals revealed that it may play a cardioprotective role [Citation26]. In addition, Fendrr polymorphism was recently found to be significantly associated with the risk of developing hypertrophic cardiomyopathy (HCM) using NGS. This study found that rare alleles in the Fendrr polymorphism were significantly protective against HCM [Citation27]. lncRNA Fendrr was significantly upregulated in a mouse model of MI/R injury and could interact with nucleolin in cardiomyocytes. Moreover, overexpression of lncRNA Fendrr plays a protective role against H2O2-induced injury in cardiomyocytes. Also, Fendrr is involved in the myocardial protective role of nucleolin during oxidative stress. Therefore, lncRNA Fendrr could be a new biomarker for the early diagnosis, therapeutic target, and prognosis prediction of heart diseases.
LncRNA-protein interactions primarily reveal the post-transcriptional regulatory mechanism. So far, research has revealed related molecular mechanisms of the interaction between long noncoding RNA and nucleolin, which could lead to a plethora of useful targets for disease diagnosis and prevention. For example, lncRNA CYP4B1-PS1-001 may influence nucleolin ubiquitination and degradation, making it a promising target for diabetic nephropathy [Citation15]. The lncRNA CYTOR is significantly upregulated in colon cancer tissue samples and is associated with poor prognosis. The complex formed by the CYTOR-nucleolin interaction activates signaling pathways that promote colon cancer progression [Citation28]. Our inference that Fendrr is important for the protective role of nucleolin implies that nucleolin may exert a protective function by interacting with Fendrr during cardiomyocyte injury and provides a new perspective on the mechanism through which nucleolin protects against myocardial injury.
The function of nucleolin depends mainly on the RNA-binding domain in the central region [Citation29]. Nucleolin binds to the G-rich regions of mRNA and lncRNAs. Also, nucleolin combines with the G-rich regions of SNHG1, which partially indicates the nuclear retention of SNHG1 in disease states [Citation30]. Additionally, nucleolin directly binds to lncRNA Dnm3os and enhances Dnm3os-induced inflammation-related gene expression [Citation31]. Nucleolin can also protect cardiomyocytes from DOX-induced damage by interacting with miR-21 and upregulating miR-21 expression [Citation32]. Our results suggest that nucleolin may play a protective role in myocardial injury by binding to Fendrr and regulating its expression. Thus, exploring the answers for questions such as what is the specific mechanism underlying nucleolin regulation of Fendrr in cardiomyocytes and other molecules mechanism would provide researchers with an in-depth knowledge of the pathogenesis of myocardial injury and target identification for its prevention and treatment. These questions will be our future studies direction, and other researchers are welcome to explore with us.
Conclusions
In conclusion, we discovered that lncRNA Fendrr plays an important role in the cardioprotective effect of nucleolin against H2O2-induced injury. lncRNA Fendrr may be a potential therapeutic target for myocardial injury during oxidative stress.
Authors’ contributions
Bimei Jiang conceived and designed the project. Cheng Chen and Xiaofang Lin conducted the majority of the experiments and analyzed the data. Yuting Tang, Hui Sun, Leijing Yin, Zhengyang Luo, and Shuxin Wang performed some experiments. Cheng Chen and Xiaofang Lin wrote this manuscript. Cheng Chen and Xiaofang Lin are the co-first authors. All authors have read and approved the final manuscript.
Ethical approval
This study was approved by the Clinical Ethics Committee of the Central South University.
Acknowledgments
We thank Taylor & Francis Editing Services Team (www.tandfeditingservices.com) and AiMi Academic Services (www.aimieditor.com) for the English language editing and review services.
Data availability statement
The data used and analyzed during the current study are available from the corresponding author upon reasonable request.
Disclosure statement
No potential conflict of interest was reported by the author(s).
Additional information
Funding
References
- Tajrishi MM, Tuteja R, Tuteja N. Nucleolin: the most abundant multifunctional phosphoprotein of nucleolus. Commun Integr Biol. 2011 May;4(3):267–275.
- Andersen JS, Lyon CE, Fox AH, et al. Directed proteomic analysis of the human nucleolus. Curr Biol. 2002 Jan 8;12(1):1–11.
- Jia W, Yao Z, Zhao J, et al. New perspectives of physiological and pathological functions of nucleolin (NCL). Life Sci 2017 Oct 1;186:1–10.
- Wang K, Deng G, Chen G, et al. Heat shock protein 70 inhibits hydrogen peroxide-induced nucleolar fragmentation via suppressing cleavage and down-regulation of nucleolin. Cell Stress Chaperones. 2012 Jan;17(1):121–130.
- Zhang B, Wang H, Jiang B, et al. Nucleolin/C23 is a negative regulator of hydrogen peroxide-induced apoptosis in HUVECs. Cell Stress Chaperones. 2010 May;15(3):249–257.
- Jiang B, Zhang B, Liang P, et al. Nucleolin/C23 mediates the antiapoptotic effect of heat shock protein 70 during oxidative stress. FEBS J. 2010 Feb;277(3):642–652.
- Jiang B, Zhang B, Liang P, et al. Nucleolin protects the heart from ischaemia-reperfusion injury by up-regulating heat shock protein 32. Cardiovasc Res. 2013 Jul 1;99(1):92–101.
- Jiang B, Liang P, Wang K, et al. Nucleolin involved in myocardial ischaemic preconditioning via post-transcriptional control of HSPA1A expression. Cardiovasc Res. 2014 Apr 1;102(1):56–67.
- Liu J, Li Y, Lin B, et al. Hbl1 is a human long noncoding RNA that modulates cardiomyocyte development from pluripotent stem cells by counteracting MIR1. Dev Cell. 2017 Aug 21;42(4):333–348.e5.
- Boon RA, Jae N, Holdt L, et al. Long noncoding RNAs: from clinical genetics to therapeutic targets? J Am Coll Cardiol. 2016 Mar 15;67(10):1214–1226.
- Piccoli MT, Gupta SK, Viereck J, et al. Inhibition of the cardiac fibroblast-enriched lncRNA Meg3 prevents cardiac fibrosis and diastolic dysfunction. Circ Res. 2017 Aug 18;121(5):575–583.
- Song C, Qi H, Liu Y, et al. Inhibition of lncRNA Gm15834 attenuates autophagy-mediated myocardial hypertrophy via the miR-30b-3p/ULK1 axis in mice. Mol Ther: J Am Soc Gene Ther. 2021 Mar 3;29(3):1120–1137.
- Chen C, Liu M, Tang Y, et al. LncRNA H19 is involved in myocardial ischemic preconditioning via increasing the stability of nucleolin protein. J Cell Physiol. 2020 Sep;235(9):5985–5994.
- Wu Q, Wang R, Shi Y, et al. Synthesis and biological evaluation of panaxatriol derivatives against myocardial ischemia/reperfusion injury in the rat. Eur J Med Chem. 2020 Jan 1;185:111729.
- Wang S, Chen X, Wang M, et al. Long non-coding RNA CYP4B1-PS1-001 inhibits proliferation and fibrosis in diabetic nephropathy by interacting with nucleolin. Cell Physiol Biochem. 2018;49(6):2174–2187.
- Zhang G, Wang Q, Zhang X, et al. LncRNA FENDRR suppresses the progression of NSCLC via regulating miR-761/TIMP2 axis. Biomed Pharmacother. 2019 Oct;118:109309.
- Zhang M, Cheng K, Chen H, et al. LncRNA AK020546 protects against cardiac ischemia-reperfusion injury by sponging miR-350-3p. Aging. 2021 May 13;13(10):14219–14233.
- Lu M, Tian H, Cao YX, et al. Downregulation of miR-320a/383-sponge-like long non-coding RNA NLC1-C (narcolepsy candidate-region 1 genes) is associated with male infertility and promotes testicular embryonal carcinoma cell proliferation. Cell Death Dis. 2015 Nov 5;6(11):e1960.
- Huang M, Huang X, Jiang B, et al. Linc00174-EZH2-ZNF24/Runx1-VEGFA regulatory mechanism modulates post-burn wound healing. Molecular Therapy Nucleic Acids. 2020 Sep 4;21:824–836.
- Grote P, Wittler L, Hendrix D, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell. 2013 Jan 28;24(2):206–214.
- Li Y, Zhang W, Liu P, et al. Long non-coding RNA FENDRR inhibits cell proliferation and is associated with good prognosis in breast cancer. Onco Targets Ther. 2018;11:1403–1412.
- Rosello-Lleti E, Rivera M, Cortes R, et al. Influence of heart failure on nucleolar organization and protein expression in human hearts. Biochem Biophys Res Commun. 2012 Feb 10;418(2):222–228.
- Xu TP, Huang MD, Xia R, et al. Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression. J Hematol Oncol. 2014 Aug 29;7:63.
- Kun-Peng Z, Xiao-Long M, Chun-Lin Z. LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1. Oncotarget. 2017 Sep 22;8(42):71881–71893.
- Liu J, Du W. LncRNA FENDRR attenuates colon cancer progression by repression of SOX4 protein. Onco Targets Ther. 2019;12:4287–4295.
- Kontaraki JE, Marketou ME, Kochiadakis GE, et al. The long non-coding RNAs MHRT, FENDRR and CARMEN, their expression levels in peripheral blood mononuclear cells in patients with essential hypertension and their relation to heart hypertrophy. Clin Exp Pharmacol Physiol. 2018 Nov;45(11):1213–1217.
- Cuesta-Llavona E, Lorca R, Rolle V, et al. Association of the genetic variation in the long Non-coding RNA FENDRR with the risk of developing hypertrophic cardiomyopathy. Life. 2022 May 30;12(6).
- Wang X, Yu H, Sun W, et al. The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68. Mol Cancer. 2018 Jul 31;17(1):110.
- Ginisty H, Sicard H, Roger B, et al. Structure and functions of nucleolin. J Cell Sci. 1999;112(Pt 6):761–772.
- Shen Y, Liu S, Fan J, et al. Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions. EMBO Rep. 2017 Apr;18(4):536–548.
- Wang F, Zhou S, Qi D, et al. Understanding the effects of coordination and self-assembly on an emissive phenothiazine. J Am Chem Soc 2019 Feb 27;141(8):3717–3722.
- Sun H, Tong Z, Fang Y, et al. Nucleolin protects against doxorubicin-induced cardiotoxicity via upregulating microRNA-21. J Cell Physiol. 2018 Dec;233(12):9516–9525.